Skip to Content
MilliporeSigma

Skip To

S0278

(±)-Sotalol hydrochloride

≥98% (TLC), powder, β-Adrenoceptor antagonist

Synonym(s):

N-[4-[1-Hydroxy-2-(isopropylamino)ethyl]phenyl]methanesulfonamide hydrochloride

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Size/SKUAvailabilityPrice
25 mg
Check Cart for Availability
$124.00
100 mg
Check Cart for Availability
$401.00

About This Item

Empirical Formula (Hill Notation):
C12H20N2O3S · HCl
CAS Number:
Molecular Weight:
308.82
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
EC Number:
213-496-0
MDL number:
Assay:
≥98% (TLC)
Form:
powder

$124.00


Check Cart for Availability

​
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Product Name

(±)-Sotalol hydrochloride, ≥98% (TLC), powder

Quality Segment

assay

≥98% (TLC)

form

powder

color

white to off-white

solubility

H2O: 20 mg/mL

originator

Bayer

SMILES string

Cl.CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1

InChI

1S/C12H20N2O3S.ClH/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17;/h4-7,9,12-15H,8H2,1-3H3;1H

InChI key

VIDRYROWYFWGSY-UHFFFAOYSA-N

Gene Information

Application

(±)-Sotalol hydrochloride has been used to test its effect on the cardiac action potential (AP) in human hearts. It has also been used as an β- blocker to determine its effect on free intracellular calcium (Ca2+) release and whole-cell currents in mammalian cancer cells.

Biochem/physiol Actions

Potent β-adrenoceptor antagonist; class III antiarrhythmic; prolongs the action potential and increases the refractory period.
Sotalol has a potential to block non-cardioselective β-adrenergic receptors. It acts as an anti-arrhythmic agent and is used as a therapeutic for equine arrhythmias. In addition, sotalol also has an ability to stop atrial fibrillation recurrence.

Features and Benefits

This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Bayer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
PHR2798BP4981617408
description

≥98% (TLC), powder

description

-

description

British Pharmacopoeia (BP) Reference Standard

description

United States Pharmacopeia (USP) Reference Standard

form

powder

form

-

form

crystalline

form

-

assay

≥98% (TLC)

assay

-

assay

-

assay

-

Quality Level

200

Quality Level

300

Quality Level

-

Quality Level

-

solubility

H2O: 20 mg/mL

solubility

-

solubility

-

solubility

-

originator

Bayer

originator

-

originator

-

originator

-

color

white to off-white

color

-

color

-

color

-


Storage Class

11 - Combustible Solids

WGK

WGK 3

Flash Point (°F)

Not applicable

Flash Point (°C)

Not applicable

PPE (personal protective equipment)

dust mask type N95 (US), Eyeshields, Gloves



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library




Questions

Reviews

No rating value

Active Filters